We are live on
!
Find out more
MCIM
Meadow Creek Investment Management Portfolio holdings
AUM
$5.09B
1-Year Est. Return
5.82%
This Fund
S&P 500
This Quarter
Est. Return
+8.13%
1 Year Est. Return
+5.82%
3 Year Est. Return
+54.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.08B
AUM Growth
+$339M
(+7.2%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
1,359
New
52
Increased
851
Reduced
318
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$19.3M |
| 2 |
ExxonMobil
XOM
|
+$17.5M |
| 3 |
Teladoc Health
TDOC
|
+$16.2M |
| 4 |
Shopify
SHOP
|
+$15M |
| 5 |
Intel
INTC
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$25.8M |
| 2 |
SLB Ltd
SLB
|
+$20.5M |
| 3 |
MSC Industrial Direct
MSM
|
+$18.4M |
| 4 |
CA
CA, Inc.
CA
|
+$18.1M |
| 5 |
Adobe
ADBE
|
+$17.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.85% |
| 2 | Healthcare | 15.75% |
| 3 | Financials | 14.65% |
| 4 | Consumer Discretionary | 13.48% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Tredegar Corp
TG
$281M
| $72K | ﹤0.01% |
3,322
+374
| +13% | +$8.57K |
|
|
EIDX
1252
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $70K | ﹤0.01% |
7,040
+4,496
| +177% | +$73.9K |
|
1253
Cenovus Energy
CVE
$55.6B
| $69K | ﹤0.01% |
7,028
+6,048
| +617% | +$59K |
|
1254
World Acceptance Corp
WRLD
$884M
| $68K | ﹤0.01% |
592
+336
| +131% | +$38.6K |
|
1255
Central Pacific Financial
CPF
$997M
| $67K | ﹤0.01% |
2,548
+1,708
| +203% | +$48.4K |
|
1256
Adeia
ADEA
$3.1B
| $66K | ﹤0.01% |
16,692
+3,326
| +25% | +$14.2K |
|
1257
Spotify
SPOT
$101B
| $64K | ﹤0.01% |
+352
| New | +$64.6K |
|
|
ANDV
1258
DELISTED
Andeavor
ANDV
| $64K | ﹤0.01% |
416
-320
| -43% | -$47.2K |
|
|
ASRT
1259
DELISTED
Assertio
ASRT
| $63K | ﹤0.01% |
178
+50
| +39% | +$21.8K |
|
|
CIVI
1260
DELISTED
Civitas Resources
CIVI
| $63K | ﹤0.01% |
+2,112
| New | +$70.4K |
|
1261
LivePerson
LPSN
$34.1M
| $62K | ﹤0.01% |
+160
| New | +$59K |
|
|
GG
1262
DELISTED
Goldcorp Inc
GG
| $62K | ﹤0.01% |
6,144
+4,736
| +336% | +$55.5K |
|
1263
ArcelorMittal
MT
$55.9B
| $61K | ﹤0.01% |
1,968
| – | – |
|
1264
OneSpan
OSPN
$609M
| $60K | ﹤0.01% |
3,136
+544
| +21% | +$10.2K |
|
|
OBSV
1265
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $60K | ﹤0.01% |
3,332
| – | – |
|
1266
Griffon
GFF
$4.75B
| $58K | ﹤0.01% |
3,586
+748
| +26% | +$13.4K |
|
1267
TransAlta
TAC
$3.92B
| $57K | ﹤0.01% |
10,252
| – | – |
|
1268
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$460M
| $56K | ﹤0.01% |
1,680
| – | – |
|
|
ESIO
1269
DELISTED
Electro Scientific Industries
ESIO
| $55K | ﹤0.01% |
3,152
+560
| +22% | +$10.9K |
|
1270
Conduent
CNDT
$241M
| $51K | ﹤0.01% |
+2,268
| New | +$46.5K |
|
1271
eHealth
EHTH
$39.7M
| $50K | ﹤0.01% |
1,760
+336
| +24% | +$8.92K |
|
1272
Metallus
MTUS
$900M
| $50K | ﹤0.01% |
3,376
+480
| +17% | +$7.2K |
|
1273
Dianthus Therapeutics
DNTH
$6.29B
| $46K | ﹤0.01% |
242
| – | – |
|
|
NPKI
1274
NPK International
NPKI
$1.19B
| $46K | ﹤0.01% |
+4,452
| New | +$45.5K |
|
1275
Applied Optoelectronics
AAOI
$11.7B
| $45K | ﹤0.01% |
1,824
+480
| +36% | +$18.8K |
|
Similar funds
FIM
GHCM
EP
MIH
FCM
NA
TAM
TAM
Meadow Creek Investment Management's Q3 2018 Portfolio in Review
As of Q3 2018, Meadow Creek Investment Management held 1,359 positions worth $5.08B, up 7.2% from $4.74B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Meadow Creek Investment Management's Q3 2018 filing shows 52 new, 851 increased, 318 reduced and 42 closed positions. Its largest new stake was VICI Properties: 146,778 shares worth $3.17M. The largest sale was Gilead Sciences, an estimated $25.8M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Meadow Creek Investment Management's largest Q3 2018 buy was VICI Properties: 146,778 shares worth $3.17M.
- Meadow Creek Investment Management added most to Merck in Q3 2018, an estimated $19.3M increase.
- Meadow Creek Investment Management's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $25.8M.
- Meadow Creek Investment Management fully exited Goldman Sachs ActiveBeta Japan Equity ETF in Q3 2018, selling an estimated $3.16M.
- Meadow Creek Investment Management's ten largest holdings make up 22% of its $5.08B portfolio in Q3 2018.
- Meadow Creek Investment Management opened 52 new positions and closed 42 in Q3 2018.
- Meadow Creek Investment Management's portfolio value rose 7.2% quarter-over-quarter to $5.08B.
Based on Meadow Creek Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.